AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
3.890
+0.120 (3.18%)
At close: Jan 21, 2026, 4:00 PM EST
3.810
-0.080 (-2.06%)
After-hours: Jan 21, 2026, 7:03 PM EST
AVITA Medical Market Cap
AVITA Medical has a market cap or net worth of $118.92 million as of January 21, 2026. Its market cap has decreased by -64.53% in one year.
Market Cap
118.92M
Enterprise Value
139.77M
1-Year Change
-64.53%
Ranking
Category
Stock Price
$3.89
Market Cap Chart
Since October 2, 2019, AVITA Medical's market cap has decreased from $666.70M to $118.92M, a decrease of -82.16%. That is a compound annual growth rate of -23.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 115.00M | 9.32% |
| Dec 31, 2025 | 105.20M | -68.65% |
| Dec 31, 2024 | 335.60M | -4.28% |
| Dec 29, 2023 | 350.60M | 112.23% |
| Dec 30, 2022 | 165.20M | -44.68% |
| Dec 31, 2021 | 298.60M | -25.68% |
| Dec 31, 2020 | 401.80M | -52.81% |
| Dec 31, 2019 | 851.40M | 27.70% |
| Oct 2, 2019 | 666.70M | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 289.32B |
| Novartis AG | 278.23B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 261.50B |